Exenatide-loaded inside-porous poly(lactic-co-glycolic acid) microspheres as a long-acting drug delivery system with improved release characteristics

Exenatide-loaded inside-porous poly(lactic-co-glycolic acid) microspheres as a long-acting drug delivery system with improved release characteristics

The glucagon-like peptide-1 receptor agonist exenatide (EXT) is an effective treatment for type 2 diabetes. However, this peptide has a short biological half-life and the delayed release characteristic of current formulations limit its clinical application. Herein, we prepared EXT-loaded inside-poro...

Full description

Bibliographic Details
Main Authors:	Junqiu Zhai, Zhanlun Ou, Liuting Zhong, Yu-e Wang, Li-Ping Cao, Shixia Guan
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-01-01
Series:	Drug Delivery
Subjects:	exenatide inside-porous microspheres long-acting release behavior type 2 diabetes
Online Access:	http://dx.doi.org/10.1080/10717544.2020.1850919

Similar Items

Exenatide Microspheres for Monthly Controlled-Release Aided by Magnesium Hydroxide
by: Yuxuan Ge, et al.
Published: (2021-05-01)

Injectable sustained‐release poly(lactic‐co‐glycolic acid) (PLGA) microspheres of exenatide prepared by supercritical fluid extraction of emulsion process based on a design of experiment approach
by: Heejun Park, et al.
Published: (2023-05-01)

Synchrotron radiation-based Fourier-transform infrared spectromicroscopy for characterization of the protein/peptide distribution in single microspheres
by: Manli Wang, et al.
Published: (2015-05-01)

EFFECT OF PHARMACOLOGICAL PRECONDITIONING WITH INCRETINOMIMETICS EXENATIDE AND VILDAGLIPTIN ON THE SURVIVAL OF ISCHEMIC TISSUES
by: Alla Tarasova, et al.
Published: (2017-12-01)

Synthesis and Characterization of Porous Chitosan/Saccharomycetes Adsorption Microspheres
by: Wei Song, et al.
Published: (2022-06-01)

Two-Layer Sustained-Release Microneedles Encapsulating Exenatide for Type 2 Diabetes Treatment
by: Han Liu, et al.
Published: (2022-06-01)

Effects of Chitosan on Loading and Releasing for Doxorubicin Loaded Porous Hydroxyapatite–Gelatin Composite Microspheres
by: Meng-Ying Wu, et al.
Published: (2022-10-01)

Association between exenatide use and incidence of Alzheimer's disease
by: Bo Zhou, et al.
Published: (2021-01-01)

Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
by: Saunders WB, et al.
Published: (2016-07-01)

Exenatide for obesity in children and adolescents: Systematic review and meta-analysis
by: Bin Chen, et al.
Published: (2024-04-01)

Microstructure Formation and Characterization of Long-Acting Injectable Microspheres: The Gateway to Fully Controlled Drug Release Pattern
by: Wang M, et al.
Published: (2024-02-01)

The first successful desensitization protocol in exenatide allergy: a case report
by: Osman Ozan Yeğit, et al.
Published: (2023-01-01)

Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
by: Timothy M. E. Davis, et al.
Published: (2022-06-01)

Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
by: Alexander Sergeevich Ametov, et al.
Published: (2011-09-01)

Shear Speed-Regulated Properties of Long-Acting Docetaxel Control Release Poly (Lactic-Co-Glycolic Acid) Microspheres
by: Yuhao Zheng, et al.
Published: (2020-08-01)

Target-mediated pharmacokinetic/pharmacodynamic model based meta-analysis and dosing regimen optimization of a long-acting release formulation of exenatide in patients with type 2 diabetes mellitus
by: Hanqing Li, et al.
Published: (2015-02-01)

Preparation of Freeze-Dried Porous Chitosan Microspheres for the Removal of Hexavalent Chromium
by: Wei Song, et al.
Published: (2021-05-01)

Fluorine substituted hydroxyapatite microspheres: Template-free hydrothermal synthesis and sustained fluoride-releasing properties
by: Zhu Qing-Xia, et al.
Published: (2023-09-01)

Exenatide and Dapagliflozin Combination Enhances Sertoli Cell Secretion of Key Metabolites for Spermatogenesis
by: João C. Ribeiro, et al.
Published: (2022-05-01)

Exenatide modulates tumor–endothelial cell interactions in human ovarian cancer cells
by: Agnieszka Kosowska, et al.
Published: (2017-11-01)

Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review
by: Yabing Hua, et al.
Published: (2021-01-01)

The Changes of Lipidomic Profiles Reveal Therapeutic Effects of Exenatide in Patients With Type 2 Diabetes
by: Lin Zhang, et al.
Published: (2022-03-01)

Exenatide Use in the Management of Type 2 Diabetes Mellitus
by: Angelos Kyriacou, et al.
Published: (2010-08-01)

Ferromagnetic Cytocompatible Glass‐Ceramic Porous Microspheres for Magnetic Hyperthermia Applications
by: Jesús Molinar‐Díaz, et al.
Published: (2023-04-01)

Porous mullite ceramics prepared by hollow glass microspheres and its properties
by: ZOU Xinwei, et al.
Published: (2023-03-01)

Efficacy of exenatide, ozone, and methyl prednisolone for the recovery of infraorbital nerve paresthesia after injury in rats
by: Mehdi Abrishami, et al.
Published: (2021-01-01)

Mono-Dispersed Microspheres Locally Assembled on Porous Substrates Formed through a Microemulsion Approach
by: Jianfeng Zhang, et al.
Published: (2020-04-01)

Hierarchically porous CuO microspheres and their r-GO based nanohybrids for electrochemical supercapacitors applications
by: Sheraz Yousaf, et al.
Published: (2020-11-01)

Preparation of “Open/closed” pores of PLGA-microsphere for controlled release of protein drug
by: Odonchimeg M, et al.
Published: (2018-02-01)

Risperidone Controlled Release Microspheres Based on Poly(Lactic Acid)-Poly(Propylene Adipate) Novel Polymer Blends Appropriate for Long Acting Injectable Formulations
by: Stavroula Nanaki, et al.
Published: (2018-08-01)

New indications for exenatide therapy of type 2 diabetes mellitus
by: Olga Konstantinovna Vikulova, et al.
Published: (2010-09-01)

An experimental study of exenatide effects on renal injury in diabetic rats
by: Xiaodong Wang, et al.
Published: (2019-02-01)

Development of In Situ Microfluidic System for Preparation of Controlled Porous Microsphere for Tissue Engineering
by: Ji Hwan Han, et al.
Published: (2022-10-01)

Bioinspired porous microspheres for sustained hypoxic exosomes release and vascularized bone regeneration
by: Yike Gao, et al.
Published: (2022-08-01)

Preparation of Alginate Microspheres for the Delivery of Risperidone
by: Al-Tahami K.
Published: (2014-12-01)

Safety, Tolerability, and Proof-Of-Concept Study of OKV-119, a Novel Exenatide Long-Term Drug Delivery System, in Healthy Cats
by: Michael Klotsman, et al.
Published: (2021-05-01)

Exenatide Attenuates Non-Alcoholic Steatohepatitis by Inhibiting the Pyroptosis Signaling Pathway
by: Yu Liu, et al.
Published: (2021-04-01)

Precise Fabrication of Porous Microspheres by Iso-Density Emulsion Combined with Microfluidics
by: Yuxiao Shi, et al.
Published: (2022-06-01)

Surface functionalization of porous chitosan microsphere with silver nanoparticle and carbon dot
by: Debabrata Ghosh Dastidar, et al.
Published: (2020-01-01)

Magnetic Gelatin Microspheres for Targeted Release of Doxorubicin
by: Josefa Virginia da Silva Souza, et al.
Published: (2021-10-01)